Minimally Invasive Surgery in the Treatment of Urological Cancers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 10 August 2024 | Viewed by 171

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90127 Palermo, Italy
Interests: urology; oncologic surgery; robotic surgery; laparoscopy; prostate; bladder; kidney; penis; testis

E-Mail Website
Guest Editor Assistant
Department of Surgical, Oncological and Oral Sciences, University of Palermo, 90127 Palermo, Italy
Interests: prostate cancer; bladder cancer; kidney cancer; robotic surgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Minimally invasive surgery (MIS) has emerged as a transformative approach in the treatment of urological cancers. This Special Issue delves into the innovative techniques and outcomes associated with MIS in urological oncology. MIS, including laparoscopy and robotic-assisted procedures, offers numerous advantages such as reduced blood loss, shorter hospital stays, and faster recovery times compared to traditional open surgeries. The articles in this Special Issue explore the application of MIS in the management of various urological cancers, including prostate, kidney, bladder, and testicular cancers. Additionally, they investigate the long-term oncological outcomes, patient quality of life, and cost-effectiveness of MIS. By showcasing the latest research and clinical experiences, this Special Issue aims to advance our understanding of the role of MIS in improving patient outcomes and reshaping the landscape of urological cancer treatment.

Prof. Dr. Alchiede Simonato
Guest Editor

Nicola Pavan
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive
  • robotic
  • laparoscopic
  • uro-oncology
  • prostate cancer
  • bladder cancer
  • kidney cancer
  • testicular cancers
  • quality of life
  • penile cancer

Published Papers

This special issue is now open for submission.
Back to TopTop